UNSPSC 51442418: Ioflupane 123I

This classification denotes a radiopharmaceutical compound with the molecular formula C18H23FINO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3MM99T8R5Q, more generally known as ioflupane (123i). European Medicines Agency schedules ioflupane (123i) in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08221MIG. The term IOFLUPANE (123I) is an International Non-Proprietary Name or INN.

UNSPSC 51442418 Ioflupane 123I is a Commodity code for a radiopharmaceutical diagnostic imaging agent used in nuclear medicine scans to detect movement disorders. However, the code shows minimal recent state and local procurement activity aligned with its nominal scope. The two most recent opportunities posted under this code — a Broward County Aviation Department RFI for Rapiscan X-ray system maintenance services (June 2026) and a Pasco County RFQ for copper sulfate crystals and liquid (June 2026) — are unrelated to ioflupane or diagnostic radiopharmaceuticals. Neither solicitation reflects the medical or pharmaceutical procurement that the code itself describes, suggesting possible miscoding or administrative misalignment between the opportunities and the UNSPSC classification applied to them.

The geographic spread is limited to Florida-based issuers, with Broward County and Pasco County the only recent buyers posting under this code. No state health departments, hospital systems, medical centers, or healthcare procurement consortia appear in the recent-opportunities record for this code. The absence of relevant activity, combined with the clear mismatch between the code's pharmaceutical scope and the equipment and chemical supplies actually being solicited, indicates this code warrants close classification review before developing a pursuit strategy.